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Background
The mycobacteria become resistant since their slow
growth phase increases its ability to adapt and acquire
new resistance mechanisms. Presently the first line therapy
against TB includes the use of isoniazid and rifampin,
which are probably the most effective mycobacterial drugs
available today and then there is a very small chance to
treat the disease since other newer drugs are seriously lim-
ited by gastrointestinal, renal and/or neurological toxici-
ties. Therefore, the search for new ways to treat TB is of
primary importance and urgency. Alphalinolenic acid
(ALA) is a potent inhibitor of fatty acid synthase (FAS) in
a variety of prokaryotic and eukaryotic cells.
Methods
Using a standardized mycobacterial susceptibility test,
we have observed that ALA inhibits the growth of sev-
eral species of mycobacteria, including tuberculous spe-
cies such as Mycobacterium tuberculosis (H37Rv and
clinical isolates) and Mycobacterium bovis BCG.
Results
Alpha linolenic acids are toxic to mycobacteria, such as
Mycobacterium tuberculosis H37Rv, with minimum inhibi-
tory concentrations (MICs) of 25-50 μg/mL and Mycobac-
terium bovis with minimum inhibitory concentration of
6.25 – 25 μg/mL.
Conclusion
Our data demonstrate that ALA as a prototypical inhibi-
tor, significant antimycobactericidal effects was seen
with Mycobacterium tuberculosis and Mycobacterium
bovis. A possible antibacterial mechanism was postulated
to proceed via disruption of the bacterial cell membrane
resulting in a change in membrane permeability.
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